Sequential Ecological Relay of a BALIMONT Multi-Strain Probiotic Platform for Weight Management and Metabolic Environment Modulation
DOI:
https://doi.org/10.62051/ijafsr.v4n1.09Keywords:
BALIMONT, Bacillus coagulans, Bifidobacterium animalis, Lactobacillus plantarum, Weight management, Metabolic environment, Short-chain fatty acids, Probiotic synergyAbstract
We evaluated a BALIMONT multi-strain probiotic platform composed of Bacillus coagulans ATCC 7050, Bifidobacterium animalis ATCC 27536, and Lactobacillus plantarum DSM 20174, and we integrated the original formulation dataset with currently available published evidence relevant to probiotic-based weight management. The platform used a 1:1:1 viable-count ratio and a sequential ecological-relay design in which B. animalis and L. plantarum were pre-incubated in a B. coagulans cell-free metabolite filtrate before final blending with B. coagulans spore powder. In the original comparative dataset, six-month viable-count retention reached 85.2%, versus 52.0% for a same-strain direct-mix comparator. In vivo, B. coagulans first reduced free oxygen from 5.2 mg/L to 0.8 mg/L and shifted the proximal intestinal redox potential from +120 mV to −180 mV, followed by jejunal/ileal enrichment of L. plantarum and distal-colon enrichment of B. animalis. In obese mice, the medium and high doses reduced body weight by 12.3% and 15.7%, body-fat percentage by 18.5% and 22.4%, and colonic short-chain fatty acids by 58% and 72%, respectively, relative to the model pattern reported in the source dataset. Published human studies and meta-analyses further support the plausibility of probiotic-mediated improvement in visceral fat, body weight, insulin resistance, and microbiota-related metabolic markers. Together, these data support BALIMONT as a process-defined probiotic platform for metabolic-environment modulation and justify further randomized human validation.
Downloads
References
[1] World Health Organization. Obesity and overweight. Fact sheet. Updated 8 December 2025.
[2] Markowiak-Kopeć P, Śliżewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients. 2020; 12(4):1107.
[3] Huang J, Jiang R, Wang Y. Effects of the probiotic Bacillus coagulans BC69 on the metabolic and histological alterations induced by a high-sugar and high-fat diet in C57BL/6J mice. Food Funct. 2023; 14:6596-6609.
[4] Wang R, Zhang G, Wang X, et al. Effect of Bacillus coagulans BC99 supplementation on body weight and gut microbiota in overweight and obese individuals: a randomized, double-blind, placebo-controlled study. Front Nutr. 2025.
[5] Takahashi S, Anzawa D, Takami K, et al. Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial. Biosci Microbiota Food Health. 2016;35(4):163-171.
[6] Sohn M, Lee J, et al. Effect of Lactobacillus plantarum LMT1-48 on body fat in overweight subjects: a randomized, double-blind, placebo-controlled trial. Diabetes Metab J. 2023; 47:91-103.
[7] Li C-P, Chen J, et al. The role of Lactobacillus plantarum in reducing obesity and inflammation: a meta-analysis. Int J Mol Sci. 2024; 25(14):7608.
[8] Cao N, Zhang Y, et al. Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: a meta-analysis of randomized controlled trials. Clin Nutr Open Sci. 2024; 56:166-176.
[9] Cho E, Kim JY, Cho B, et al. Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial. Front Nutr. 2023; 10:1148512.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







